Puerarin ameliorates metabolic dysfunction-associated fatty liver disease by inhibiting ferroptosis and inflammation.

MLA

Yang, Mengmeng, et al. “Puerarin Ameliorates Metabolic Dysfunction-Associated Fatty Liver Disease by Inhibiting Ferroptosis and Inflammation.” Lipids in Health & Disease, vol. 22, no. 1, Nov. 2023, pp. 1–16. EBSCOhost, https://doi.org/10.1186/s12944-023-01969-y.

APA

Yang, M., Xia, L., Song, J., Hu, H., Zang, N., Yang, J., Zou, Y., Wang, L., Zheng, X., He, Q., Liu, J., Liu, F., Liang, K., Sun, L., & Chen, L. (2023). Puerarin ameliorates metabolic dysfunction-associated fatty liver disease by inhibiting ferroptosis and inflammation. Lipids in Health & Disease, 22(1), 1–16. https://doi.org/10.1186/s12944-023-01969-y

Chicago

Yang, Mengmeng, Longqing Xia, Jia Song, Huiqing Hu, Nan Zang, Jingwen Yang, Ying Zou, et al. 2023. “Puerarin Ameliorates Metabolic Dysfunction-Associated Fatty Liver Disease by Inhibiting Ferroptosis and Inflammation.” Lipids in Health & Disease 22 (1): 1–16. doi:10.1186/s12944-023-01969-y.